Cincinnati Children’s Hospital Conducting Phase I/II Clinical Trial Investigating BNT 162 COVID-19 Vaccine

Representing one of four sites across the United States, principal investigator and former Naval Officer Dr. Robert Frenck at Cincinnati Children’s Hospital is leading the Phase I/2 trials investigating the BNT 162 COVID-19 vaccine. Developed by a German biotech...

Pin It on Pinterest